Analyst Conference Summaries

Biotechnology Investor Aids

Alexion Pharmaceuticals
ALXN

conference date: February 4, 2021 @ 5:00 AM Pacific Time

Alexion: A Good Buy For Long Term Appreciation [July 4, 2019 @ Seeking Alpha]

Alexion: Priced Right For Long-Term Investors [August 16, 2018 at Seeking Alpha]

I buy Alexion [February 3, 2015 at Dissecting the Bull]

Alexion's Rare Disease Model Analyzed [December 18, 2014 @ Seeking Alpha]

2021
Alexion
Q4 2020
To be acquired by AstraZeneca    
Feb. 4, 2021      
2020
Alexion
Q4 2019
Alexion
Q1 2020
Alexion
Q2 2020
Alexion
Q3 2020
Jan. 30, 2020 May 6, 2020 July 30, 2020 Oct. 29, 2020
2019
Alexion
Q4 2018
Alexion
Q1 2019
Alexion
Q2 2019
Alexion
Q3 2019
Feb. 4, 2019 April 25, 2019 July 24, 2019 Oct. 23, 2019
2018
Feb. 8, 2018
April 12, 2018
July 26, 2018
Oct. 24, 2018
2017
02/16/2017
 04/27/2017
July 27, 2017
Oct. 26, 2017
2016
02/03/2016
04/28/2016
07/28/2016
10/27/2016
2015
01/29/2015
05/23/2015
07/30/2015
10/29/2015
2014
01/30/2014
04/24/2014
07/24/2014
10/23/2014
2013
 
 
 
 
 07/25/2013
10/24/2013 

Alexion Pharmaceuticals (ALXN) is a biotechnology company specializing in rare blood disorders.

Alexion web site
Alexion investor relations page

I owned Alexion between February 3, 2015 and May 18, 2017, took my losses, illustrating the danger in investing in a priced-over-perfection stock. Price was pretty reasonable when I sold it, but I had just had a major gain with GlycoMimetics, and decided to reduce my debt.

I reserve the right to buy or sell the stock at any time without notice. Investors are welcome to read my notes and opinions, which are journalism, not financial advice.

 

Search

More Analyst Conference Pages:

 AGEN
 ALNY
 ALXN
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BMY
 CELG
 DRNA
 EPZM
 GILD
 GLYC
 ILMN
 INCY
 INO
 IONS
 ISRG
 MCHP
 MRNA
 REGN
 RNA
 SGEN
 TTPH
 VBLT
 VSTM
 XLRN

 

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but it is possible. Before making or terminating an investment you should always verify any factual basis of your decision.

Copyright 2020 William P. Meyers